Corient Private Wealth’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.8M Buy
184,510
+43,222
+31% +$3.88M 0.02% 461
2025
Q4
$8.86M Buy
141,288
+93,306
+194% +$7.08M 0.01% 819
2025
Q3
$2.75M Buy
47,982
+1,252
+3% +$72.1K ﹤0.01% 935
2025
Q2
$2.76M Buy
46,730
+310
+0.7% +$20K ﹤0.01% 904
2025
Q1
$3.4M Sell
46,420
-18,924
-29% -$1.56M 0.01% 802
2024
Q4
$5.4M Sell
65,344
-7,985
-11% -$630K 0.01% 674
2024
Q3
$5.25M Sell
73,329
-3,139
-4% -$222K 0.01% 736
2024
Q2
$5.24M Buy
76,468
+244
+0.3% +$14.6K 0.01% 698
2024
Q1
$4.09M Buy
76,224
+2,204
+3% +$118K 0.01% 765
2023
Q4
$3.94M Buy
74,020
+2,038
+3% +$99.3K 0.01% 767
2023
Q3
$3.57M Buy
71,982
+1,393
+2% +$77.9K 0.01% 723
2023
Q2
$4.2M Buy
70,589
+7,219
+11% +$411K 0.01% 678
2023
Q1
$3.59M Buy
63,370
+175
+0.3% +$11.2K 0.01% 679
2022
Q4
$4.69M Buy
+63,195
New +$4.3M 0.02% 520

Other funds holding GMED